Metastatic Patterns and Prognosis ofde novoMetastatic Nasopharyngeal Carcinoma in theUnited States

作者：Xu, Yali; Huang, Taoyuan; Mao, Min; Zhai, Jinming; Chen, Jinhai^*

来源：Laryngoscope, 2021, 131(4): E1130-E1138.

DOI：10.1002/lary.28983

• Nasopharyngeal carcinoma
• metastasis
• prognosis
• SEER

Objective To evaluate the distant metastatic patterns and prognostic factors for overall survival (OS) and cancer-specific survival (CSS) inde novometastatic nasopharyngeal carcinoma (mNPC) using the Surveillance, Epidemiology, and End Results (SEER) database. Methods Patients withde novomNPC who had been diagnosed between 2004 and 2016 were identified from the SEER database. Kaplan-Meier analysis was used to calculate OS and CSS. Log-rank tests were employed to measure survival variation among subgroups. Individual predictors of CSS and OS were examined using Cox proportional-hazards regression models in patients withde novomNPC. Results We evaluated 224 patients withde novomNPC who matched our inclusion criteria. Three-year CSS and OS for the whole cohort was 29.8% and 27.9%, respectively. Univariate analysis indicated that CSS and OS were influenced by age, histology, radiotherapy, chemotherapy, and liver metastasis. Neither the number of metastatic sites nor their specific location in bone, lungs, distant lymph nodes or brain significantly affected CSS or OS. The aforementioned independent prognosticators continued to significantly influence survival following multivariate analysis. Taking distant metastasis without liver involvement as a reference, liver metastasis was associated significantly with shorter OS at a hazard ratio (HR) of 1.581 (P= .021) and CSS at a HR of 1.643 (P= .016). Older age, keratinizing squamous cell carcinoma, no chemotherapy, and no radiotherapy were also prognosticators for poor OS (P < .05). Similar results were documented for CSS (P < .05). Conclusion For patients withde novomNPC, liver metastasis is an independent prognosticator for inferior CSS and OS. Level of Evidence 3aLaryngoscope, 2020

• 单位
  广州医学院; 南方医科大学